Thomas Charles Reilly Cara Therapeutics, Inc. (CARA) insider trading activity
Thomas Charles Reilly is Chief Financial Officer of Cara Therapeutics, Inc.. Currently has a direct ownership of 37,811 shares of CARA, which is worth approximately $11,343. The most recent transaction as insider was on Mar 03, 2022, when has been sold 2,044 shares (Common Stock) at a price of $11.38 per share, resulting in proceeds of $23,261. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
37.8K
0%
3M change
0%
12M change
Total Value Held
$11,343
Thomas Charles Reilly Transaction History
Also insider at
TCR
Thomas Charles Reilly
Chief Financial Officer
Bridgewater, NJ